Release Date: 15/10/20 10:26 Summary: OPTICOMM ACQUISITION - REVISED SUPERIOR PROPOSAL Price Sensitive: Yes Download Document 1.2MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling